-
CorePharma launches generic Ritalin
MIDDLESEX, N.J. — CorePharma on Thursday announced the launch of methylphenidate hydrochloride tablets USP, the generic version of Ritalin from Novartis. Methylphenidate is intended for the treatment of narcolepsy and attention deficit disorders.
The drug is available in 5-,10- and 20-mg strengths. Methylphenidate immediate release tablets had U.S. sales of approximately $243 million as of December 2013, according to IMS Data. -
Ajanta Pharma launches risperidone tablets
BRIDGEWATER, N.J. — Ajanta Pharma USA on Friday announced the launch of risperidone tablets (0.25-mg, 0.5-mg, 1-mg, 2-mg, 3-mg and 4-mg), the generic version of Risperdal. The drug is used to treat schizophrenia and bipolar disorder.
Sales of branded and generic risperidone totalled approximately $147 million for the 12 months ending March 2014, according to IMS Health.